Education
About Us
Working with TipRanks
Follow Us
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
ARTL Analyst Ratings
Hold
0 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ARTL Stock 12 Month Forecast
Average Price Target
$5.00
▼(-47.37%Downside)
| Highest Price Target$5.00 | Average Price Target$5.00 | Lowest Price Target$5.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
D. Boral Capital
―
Hold
―
Downgraded
06/11/25
H.C. Wainwright
$5
Buy
-47.37%
Downside
Reiterated
03/04/25
Analysts Are Bullish on Top Healthcare Stocks: Artelo Biosciences (ARTL), Syndax Pharmaceuticals (SNDX)Valuation and Risks. Our $5 PT was derived by using a discount rate of 25% for Artelo shares to discount free cash flows from our projection of annual sales of ART27.13 in cancer anorexia and cachexia syndrome (CACS), 2028-2033, and dividing them by our projected number of shares for each year to account for the effects of share dilution. We then factored in a 2% terminal growth rate, and a 60% clinical program probability of success.
Maxim Group
$5
Buy
-47.37%
Downside
Reiterated
12/09/24
Ladenburg Thalmann & Co.
$40
Buy
321.05%
Upside
Reiterated
08/14/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
D. Boral Capital
―
Hold
―
Downgraded
06/11/25
H.C. Wainwright
$5
Buy
-47.37%
Downside
Reiterated
03/04/25
Analysts Are Bullish on Top Healthcare Stocks: Artelo Biosciences (ARTL), Syndax Pharmaceuticals (SNDX)Valuation and Risks. Our $5 PT was derived by using a discount rate of 25% for Artelo shares to discount free cash flows from our projection of annual sales of ART27.13 in cancer anorexia and cachexia syndrome (CACS), 2028-2033, and dividing them by our projected number of shares for each year to account for the effects of share dilution. We then factored in a 2% terminal growth rate, and a 60% clinical program probability of success.
Maxim Group
$5
Buy
-47.37%
Downside
Reiterated
12/09/24
Ladenburg Thalmann & Co.
$40
Buy
321.05%
Upside
Reiterated
08/14/24
Best Analysts Covering Artelo Biosciences
1 Month
xxx
Success Rate
8/18 ratings generated profit
Average Return
-5.68%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 44.44% of your transactions generating a profit, with an average return of -5.68% per trade.
3 Months
xxx
Success Rate
7/18 ratings generated profit
Average Return
-9.87%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 38.89% of your transactions generating a profit, with an average return of -9.87% per trade.
1 Year
Success Rate
4/18 ratings generated profit
Average Return
-20.81%
reiterated a buy rating 4 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -20.81% per trade.
2 Years
xxx
Success Rate
9/18 ratings generated profit
Average Return
-12.25%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -12.25% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ARTL Analyst Recommendation Trends
Rating
Oct 24
Nov 24
Dec 24
Mar 25
Jun 25
Strong Buy
1
0
0
0
0
Buy
4
5
5
5
3
Hold
0
0
0
0
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
5
5
5
4
Each month's total comprises the sum of three months' worth of ratings.
ARTL Financial Forecast
ARTL Stock Forecast FAQ
What is ARTL’s average 12-month price target, according to analysts?
Based on analyst ratings, Artelo Biosciences Inc’s 12-month average price target is 5.00.
What is ARTL’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for ARTL, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ARTL a Buy, Sell or Hold?
Artelo Biosciences Inc has a consensus rating of Hold which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.
What is Artelo Biosciences Inc’s price target?
The average price target for Artelo Biosciences Inc is 5.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $5.00 ,the lowest forecast is $5.00. The average price target represents -47.37% Decrease from the current price of $9.5.
The highest analyst price target is $5.00 ,the lowest forecast is $5.00. The average price target represents -47.37% Decrease from the current price of $9.5.
What do analysts say about Artelo Biosciences Inc?
Artelo Biosciences Inc’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of ARTL?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.